XML 47 R25.htm IDEA: XBRL DOCUMENT v3.20.1
Long Term Obligations (Tables)
 3 Months Ended
Mar. 31, 2020
Secured Term Loan  
Schedule of Future Principal Maturities of Secured Term Loan
As of March 31, 2020, the future principal maturities of our Secured Term Loans for each of the next five years are as follows (in thousands):
Year ended December 31,
 
2022
$
19,231

2023
19,231

2024
19,231

Thereafter
67,307

Total
$
125,000
HealthCare Royalty Partners and its Affiliates (“HCR”)  
Schedule of Payment Obligations
Our payment obligations for HCR royalty-based debt are as follows (in thousands):
 
March 31, 2020
 
December 31, 2019
Total repayment obligations
$
290,550

 
$
290,550

Less: interest to be accreted in future periods
(100,170
)
 
(104,268
)
Less: payments made
(11,420
)
 
(9,069
)
Carrying value of long term royalty-based debt
178,960

 
177,213

Less: current portion of royalties
(7,723
)
 
(14,316
)
Non-current portion of long term royalty-based debt
$
171,237

 
$
162,897
Bristol-Myers Squibb Company ("BMS") and Pfizer Inc. ("Pfizer")  
Schedule of Payment Obligations
Our payment obligations for the BMS and Pfizer Promissory Notes are as follows (in thousands):
 
March 31, 2020
 
December 31, 2019
Total repayment obligations
$
65,000

 
$
62,500

Less: interests to be accreted in future periods
(7,424
)
 
(5,565
)
Less: payments made
(6,743
)
 
(5,374
)
Carrying value of notes payable
50,833

 
51,561

Less: current portion of royalties
(4,564
)
 
(8,461
)
Non-current portion of notes payable
$
46,269

 
$
43,100